Stocksigma LogoStocksigma Logo

Sudarshan Pharma Board to Consider Q2 Results and Fund Raising

Sudarshan Pharma Industries' Board of Directors is scheduled to meet on 29th Oct'26 to consider and approve the unaudited standalone and consolidated

Sudarshan Pharma Board to Consider Q2 Results and Fund Raising

Sudarshan Pharma Industries Ltd 路 Intimation 路 29 Oct 2026, 5:30 am

Sudarshan Pharma Board to Consider Q2 Results and Fund Raising Sudarshan Pharma Industries' Board of Directors is scheduled to meet on 29th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The board will also evaluate a proposal for fund raising via equity shares, convertible securities, warrants, or debt instruments through private placement, preferential issue, Qualified Institutions Placement (QIP), or other modes, subject to regulatory approvals. The company's trading window remains closed until 48 hours post the result declaration.

Original exchange filing (PDF)

More announcements from Sudarshan Pharma Industries Ltd

All Sudarshan Pharma Industries Ltd announcements